LDL accelerates monocyte to macrophage differentiation: Effects on adhesion and anoikis

Atherosclerosis

Volumn 246, Issue , 2016, Pages 177-186

  Escate, R ^a   Padro, T ^a   Badimon, L ^a,b  

^a Institut Català de Ciències Cardiovasculars   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Anoikis; Atherosclerosis; Integrins; MicroRNAs; Monocyte

Indexed keywords

ALPHA3 INTEGRIN; CD14 ANTIGEN; CD16 ANTIGEN; DEATH RECEPTOR 5; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 126 3P; PROTEIN; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; TNFRSF10B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANOIKIS; APOPTOSIS; ARTICLE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; COMPUTER MODEL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL TRANSDIFFERENTIATION; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; TIME FACTOR;

ANOIKIS; ANTIGENS, CD14; CELL ADHESION; CELL ADHESION MOLECULES; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; GPI-LINKED PROTEINS; HUMANS; INTEGRIN ALPHA3; LIPOPROTEINS, LDL; MACROPHAGES; MICRORNAS; MONOCYTES; PHENOTYPE; RECEPTORS, IGG; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 84960356197     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.01.002     Document Type: Article

References (54)

1. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340(2):115-126.
2. Behrendt D., Ganz P. Endothelial function. From vascular biology to clinical applications. Am. J. Cardiol. 2002, 90(10c):40L-48L.
3. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105(9):1135-1143.
4. Altman R. Risk factors in coronary atherosclerosis athero-inflammation: the meeting point. Thromb. J. 2003, 1(1):4.
5. Badimon L., Padró T., Vilahur G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur. Heart J. Acute Cardiovasc. Care 2012, 1(1):60-74.
6. Pritchard K.A., Tota R.R., Lin J.H., et al. Native low density lipoprotein. Endothelial cell recruitment of mononuclear cells. Arterioscler. Thromb. Vasc. Biol. 1991, 11(5):1175-1181.
7. Han K.H., Tangirala R.K., Green S.R., Quehenberger O. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler. Thromb. Vasc. Biol. 1998, 18(12):1983-1991.
8. Smalley D.M., Lin J.H.-C., Curtis M.L., Kobari Y., Stemerman M.B., Pritchard K.A. Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule 1. Arterioscler. Thromb. Vasc. Biol. 1996, 16(4):585-590.
9. Serrano C.V., Pesaro A.E., de Lemos J.A., et al. Native LDL-cholesterol mediated monocyte adhesion molecule overexpression is blocked by simvastatin. Cardiovasc. Drugs Ther. 2009, 23(3):215-220.
10. Margadant C., Monsuur H.N., Norman J.C., Sonnenberg A. Mechanisms of integrin activation and trafficking. Curr. Opin. Cell Biol. 2011, 23(5):607-614.
11. Gilmore A.P. Anoikis. Cell Death Differ. 2005, 12(Suppl. 2):1473-1477.
12. Beauséjour M., Thibodeau S., Demers M.-J., et al. Suppression of anoikis in human intestinal epithelial cells: differentiation state-selective roles of α2β1, α3β1, α5β1, and α6β4 integrins. BMC Cell Biol. 2013, 14:53.
13. Ammon C., Meyer S.P., Schwarzfischer L., Krause S.W., Andreesen R., Kreutz M. Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells. Immunology 2000, 100(3):364-369.
14. 1-integrin over-expression in human macrophages. Int. J. Mol. Sci. 2012, 13(11):14278-14293.
15. Cha S.S., Sung B.J., Kim Y.A., et al. Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity. J. Biol. Chem. 2000, 275(40):31171-31177.
16. Elmore S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 2007, 35(4):495-516.
17. Kothakota S., Azuma T., Reinhard C., et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997, 278(5336):294-298.
18. Kamada S., Kusano H., Fujita H., et al. A cloning method for caspase substrates that uses the yeast two-hybrid system: cloning of the antiapoptotic gene gelsolin. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(15):8532-8537.
19. Laguinge L.M., Samara R.N., Wang W., et al. DR5 receptor mediates anoikis in human colorectal carcinoma cell lines. Cancer Res. 2008, 68(3):909-917.
20. Haselmann V., Kurz A., Bertsch U., et al. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells. Gastroenterology 2014, 146(1):278-290.
21. Alexiou P., Vergoulis T., Gleditzsch M., et al. miRGen 2.0: a database of microRNA genomic information and regulation. Nucleic Acids Res. 2010, 38(Database issue):D137-D141.
22. Borrell-Pagès M., Romero J.C., Badimon L. LRP5 negatively regulates differentiation of monocytes through abrogation of Wnt signalling. J. Cell. Mol. Med. 2014, 18(2):314-325.
23. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Investig. 1955, 34(9):1345-1353.
24. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95(2):351-358.
25. Cal R., Castellano J., Revuelta-López E., et al. Low-density lipoprotein receptor-related protein 1 mediates hypoxia-induced very low density lipoprotein-cholesteryl ester uptake and accumulation in cardiomyocytes. Cardiovasc. Res. 2012, 94(3):469-479.
26. Cornelissen M., Philippé J., De Sitter S., De Ridder L. Annexin V expression in apoptotic peripheral blood lymphocytes: an electron microscopic evaluation. Apoptosis 2002, 7(1):41-47.
27. Padró T., Peña E., García-Arguinzonis M., Llorente-Cortes V., Badimon L. Low-density lipoproteins impair migration of human coronary vascular smooth muscle cells and induce changes in the proteomic profile of myosin light chain. Cardiovasc Res. 2008, 77(1):211-220.
28. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008, 36:D154-D158.
29. Wagner J., Riwanto M., Besler C., et al. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler. Thromb. Vasc. Biol. 2013, 33(6):1392-1400.
30. Krüger J., Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 2006, 34:W451-W454.
31. Ziegler-Heitbrock L., Ancuta P., Crowe S., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116(16):e74-80.
32. Tanaka M., Honda J., Imamura Y., Shiraishi K., Tanaka K., Oizumi K. Surface phenotype analysis of CD16+ monocytes from leukapheresis collections for peripheral blood progenitors. Clin. Exp. Immunol. 1999, 116(1):57-61.
33. Gleissner C.A., Shaked I., Erbel C., Böckler D., Katus H.A., Ley K. CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages. Circ. Res. 2010, 106(1):203-211.
34. Walczak H., Degli-Esposti M.A., Johnson R.S., et al. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 1997, 16(17):5386-5397.
35. Lee M.-S., Cherla R.P., Lentz E.K., Leyva-Illades D., Tesh V.L. Signaling through C/EBP homologous protein and death receptor 5 and calpain activation differentially regulate THP-1 cell maturation-dependent apoptosis induced by Shiga toxin type 1. Infect. Immun. 2010, 78(8):3378-3391.
36. Lipsy R.J. Effective management of patients with dyslipidemia. Am. J. Manag. Care 2003, 9(2 Suppl):S39-S58.
37. Perk J., De Backer G., Gohlke H., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012)" the fifth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 2012, 33(13):1635-1701.
38. Ziegler-Heitbrock H.W., Ulevitch R.J. CD14: cell surface receptor and differentiation marker. Immunol. Today 1993, 14(3):121-125.
39. Rothe G., Gabriel H., Kovacs E., et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 1996, 16(12):1437-1447.
40. Krychtiuk K.A., Kastl S.P., Pfaffenberger S., et al. Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease. PLoS One 2015, 10(4):e0123367.
41. Rogacev K.S., Ulrich C., Blömer L., et al. Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur. Heart J. 2010, 31(3):369-376.
42. Kashiwagi M., Imanishi T., Tsujioka H., et al. Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris. Atherosclerosis 2010, 212(1):171-176.
43. Merino A., Buendia P., Martin-Malo A., Aljama P., Ramirez R., Carracedo J. Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. J. Immunol. 2011, 186(3):1809-1815.
44. Häkkinen T., Karkola K., Ylä-Herttuala S. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows Arch. 2000, 437(4):396-405.
45. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J. Leukoc. Biol. 2007, 81(3):584-592.
46. Schaer C.A., Schoedon G., Imhof A., Kurrer M.O., Schaer D.J. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circ. Res. 2006, 99(9):943-950.
47. Munn D.H., Beall A.C., Song D., Wrenn R.W., Throckmorton D.C. Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon gamma. J. Exp. Med. 1995, 181(1):127-136.
48. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281(5381):1322-1326.
49. Valley C.C., Lewis A.K., Mudaliar D.J., et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized. J. Biol. Chem. 2012, 287(25):21265-21278.
50. Wilson N.S., Dixit V., Ashkenazi A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol. 2009, 10(4):348-355.
51. Baetu T.M., Hiscott J. On the TRAIL to apoptosis. Cytokine Growth Factor Rev. 2002, 13(3):199-207.
52. Sun X., Zhang M., Sanagawa A., et al. Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol. Thromb. J. 2012, 10(1):16.
53. Stupack D.G., Cheresh D.A. Get a ligand, get a life: integrins, signaling and cell survival. J. Cell Sci. 2002, 115(Pt 19):3729-3738.
54. Hemler M.E. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 1990, 8:365-400.